| Primary |
| Hypertension |
22.0% |
| Helicobacter Infection |
11.9% |
| Helicobacter Gastritis |
7.1% |
| Pain |
6.9% |
| Gastrooesophageal Reflux Disease |
6.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
6.0% |
| Atrial Fibrillation |
5.0% |
| Gastritis |
3.9% |
| Urinary Tract Infection |
3.9% |
| Pneumonia |
3.0% |
| Reflux Oesophagitis |
3.0% |
| Ischaemic Heart Disease Prophylaxis |
2.8% |
| Gastric Ulcer |
2.6% |
| Type 2 Diabetes Mellitus |
2.6% |
| Essential Hypertension |
2.4% |
| Renal Transplant |
2.4% |
| Depression |
2.2% |
| Coronary Artery Disease |
1.9% |
| Hyperuricaemia |
1.9% |
| Product Used For Unknown Indication |
1.9% |
|
| Renal Failure Acute |
11.0% |
| Drug Interaction |
10.2% |
| Clostridium Difficile Colitis |
9.3% |
| Suicide Attempt |
9.3% |
| Vomiting |
6.8% |
| Hypomagnesaemia |
5.1% |
| Pancytopenia |
5.1% |
| Syncope |
5.1% |
| Tachycardia |
4.2% |
| Leukopenia |
3.4% |
| Pseudomembranous Colitis |
3.4% |
| Stevens-johnson Syndrome |
3.4% |
| Toxic Epidermal Necrolysis |
3.4% |
| Tremor |
3.4% |
| Tubulointerstitial Nephritis |
3.4% |
| Urticaria |
3.4% |
| Agranulocytosis |
2.5% |
| Bone Marrow Failure |
2.5% |
| Gastroenteritis Eosinophilic |
2.5% |
| Myasthenia Gravis |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
18.5% |
| Hypertension |
12.7% |
| Drug Use For Unknown Indication |
9.0% |
| Pain |
8.8% |
| Prophylaxis |
7.3% |
| Thrombosis Prophylaxis |
5.4% |
| Chronic Obstructive Pulmonary Disease |
4.3% |
| Supplementation Therapy |
3.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.5% |
| Fluid Replacement |
3.0% |
| Helicobacter Infection |
3.0% |
| Nausea |
2.7% |
| Pancreatitis |
2.7% |
| Psoas Abscess |
2.5% |
| Sleep Disorder |
2.5% |
| Diabetes Mellitus |
2.2% |
| Depression |
2.1% |
| Sedation |
2.1% |
| Restlessness |
2.1% |
| Essential Hypertension |
1.9% |
|
| Stevens-johnson Syndrome |
17.1% |
| Toxic Epidermal Necrolysis |
17.1% |
| Renal Failure Acute |
6.3% |
| Suicide Attempt |
6.3% |
| Vomiting |
5.9% |
| Tachycardia |
4.9% |
| Drug Interaction |
4.4% |
| Hepatitis Acute |
4.4% |
| Leukopenia |
3.9% |
| Monocytopenia |
3.9% |
| Hepatitis Cholestatic |
3.4% |
| Jaundice |
3.4% |
| Agranulocytosis |
2.9% |
| Clostridium Difficile Colitis |
2.4% |
| Jaundice Cholestatic |
2.4% |
| Somnolence |
2.4% |
| Syncope |
2.4% |
| Thrombocytopenia |
2.4% |
| Hepatitis |
2.0% |
| Myasthenia Gravis |
2.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
20.2% |
| Product Used For Unknown Indication |
18.1% |
| Hypertension |
15.6% |
| Prophylaxis |
7.2% |
| Rheumatoid Arthritis |
7.0% |
| Pain |
4.6% |
| Non-small Cell Lung Cancer |
3.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.8% |
| Thrombosis Prophylaxis |
2.3% |
| Depression |
2.2% |
| Renal Transplant |
2.1% |
| Constipation |
1.8% |
| Atrial Fibrillation |
1.7% |
| Coronary Artery Disease |
1.6% |
| Osteoporosis |
1.6% |
| Colorectal Cancer |
1.6% |
| Prophylaxis Of Nausea And Vomiting |
1.5% |
| Diabetes Mellitus |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Breast Cancer |
1.4% |
|
| Vomiting |
12.5% |
| Renal Failure Acute |
8.2% |
| Urinary Tract Infection |
7.5% |
| Syncope |
7.0% |
| Thrombocytopenia |
6.7% |
| Pyrexia |
6.4% |
| Weight Decreased |
5.8% |
| Pneumonia |
5.7% |
| Sepsis |
4.8% |
| General Physical Health Deterioration |
4.6% |
| Pulmonary Embolism |
4.3% |
| Nausea |
4.1% |
| Renal Failure |
4.0% |
| Somnolence |
3.5% |
| Respiratory Failure |
2.9% |
| Rash |
2.7% |
| Death |
2.6% |
| Drug Interaction |
2.3% |
| Tachycardia |
2.3% |
| Tremor |
2.1% |
|
| Interacting |
| Hypertension |
24.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
9.8% |
| Pain |
9.6% |
| Drug Use For Unknown Indication |
6.5% |
| Coronary Artery Disease |
5.8% |
| Pneumonia |
5.3% |
| Urinary Tract Infection |
4.9% |
| Chronic Obstructive Pulmonary Disease |
4.7% |
| Atrial Fibrillation |
4.0% |
| Ischaemic Heart Disease Prophylaxis |
3.3% |
| Leukoencephalopathy |
3.1% |
| Diabetes Mellitus |
2.7% |
| Hyperlipidaemia |
2.2% |
| Renal Failure Chronic |
2.2% |
| Hashimoto's Encephalopathy |
2.0% |
| Osteoporosis |
2.0% |
| Prophylaxis |
2.0% |
| Renal Hypertension |
2.0% |
| Helicobacter Infection |
1.8% |
| Procedural Nausea |
1.8% |
|
| Drug Interaction |
28.8% |
| Pancytopenia |
11.9% |
| Rhabdomyolysis |
11.9% |
| Pseudomembranous Colitis |
6.8% |
| Leukopenia |
5.1% |
| Urosepsis |
5.1% |
| Clostridium Difficile Colitis |
3.4% |
| Hyponatraemia |
3.4% |
| Pulmonary Embolism |
3.4% |
| Thrombocytopenia |
3.4% |
| Dyspnoea |
1.7% |
| Inappropriate Antidiuretic Hormone Secretion |
1.7% |
| Nausea |
1.7% |
| Nuclear Magnetic Resonance Imaging Abnormal |
1.7% |
| Occult Blood Positive |
1.7% |
| Paresis |
1.7% |
| Purpura |
1.7% |
| Pyrexia |
1.7% |
| Renal Failure Chronic |
1.7% |
| Sinoatrial Block |
1.7% |
|
